Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Immuneering Corp (IMRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/24/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/03/2023 4 Brakewood Harold Eugene (Chief Business Officer) has filed a Form 4 on Immuneering Corp
Txns: Granted 165,000 options @ $9.71, valued at $1.6M
04/03/2023 3 Brakewood Harold Eugene (Chief Business Officer) has filed a Form 3 on Immuneering Corp
12/27/2022 4 Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp
Txns: Exercised 2,500 options @ $3.01, valued at $7.5k
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/20/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
08/12/2022 4 Morales Mallory (VICE PRESIDENT, FINANCE) has filed a Form 4 on Immuneering Corp
Txns: Granted 10,000 options @ $6.33, valued at $63.3k
08/11/2022 3 Morales Mallory (Vice President, Finance) has filed a Form 3 on Immuneering Corp
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2022 4 Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp
Txns: Exercised 2,000 options @ $3.01, valued at $6k
03/24/2022 4 Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp
Txns: Bought 3,000 shares @ $8.02, valued at $24.1k
03/23/2022 4 Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Immuneering Corp
Txns: Bought 1,050 shares @ $7.91, valued at $8.3k
03/22/2022 4 Barrett Scott (CHIEF MEDICAL OFFICER) has filed a Form 4 on Immuneering Corp
Txns: Bought 900 shares @ $7.485, valued at $6.7k
03/16/2022 4 Feinberg Peter (Director) has filed a Form 4 on Immuneering Corp
Txns: Bought 6,667 shares @ $6.75, valued at $45k
03/15/2022 4 BERMAN ANN E (Director) has filed a Form 4 on Immuneering Corp
Txns: Bought 6,000 shares @ $6.4, valued at $38.4k
03/01/2022 4 Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp
Txns: Exercised 2,000 options @ $3.01, valued at $6k
02/14/2022 4 Amin Biren (CFO, TREASURER) has filed a Form 4 on Immuneering Corp
Txns: Granted 70,050 options @ $9.66, valued at $676.7k
02/14/2022 4 Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Immuneering Corp
Txns: Granted 83,100 options @ $9.66, valued at $802.7k
02/14/2022 4 Barrett Scott (CHIEF MEDICAL OFFICER) has filed a Form 4 on Immuneering Corp
Txns: Granted 71,850 options @ $9.66, valued at $694.1k
02/14/2022 4 Bookman Michael (GENERAL COUNSEL AND SECRETARY) has filed a Form 4 on Immuneering Corp
Txns: Granted 47,300 options @ $9.66, valued at $456.9k
02/14/2022 4 Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp
Txns: Granted 156,485 options @ $9.66, valued at $1.5M
Granted 45,615 options @ $10.63, valued at $484.9k
01/18/2022 4 HAUSMAN DIANA (Director) has filed a Form 4 on Immuneering Corp
Txns: Granted 25,200 options @ $13, valued at $327.6k
01/18/2022 3 HAUSMAN DIANA (Director) has filed a Form 3 on Immuneering Corp
12/22/2021 4 Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Immuneering Corp
Txns: Granted 322,691 shares @ $0
09/21/2021 4 Feinberg Peter (Director) has filed a Form 4 on Immuneering Corp
Txns: Bought 4,750 shares @ $24.445, valued at $116.1k
09/15/2021 4 Feinberg Peter (Director) has filed a Form 4 on Immuneering Corp
Txns: Bought 5,750 shares @ $21.5126, valued at $123.7k
Bought 349 shares @ $21.25, valued at $7.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy